Coeptis Therapeutics Holdings, Inc. (COEP)
NASDAQ: COEP · Real-Time Price · USD
0.191
-0.003 (-1.70%)
Nov 21, 2024, 12:48 PM EST - Market open
COEP Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for COEP.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for COEP.
Recommendation Trends
Rating | Apr '23 | May '23 | Jun '23 | Jul '23 | Aug '23 | Sep '23 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $3 | Strong Buy | Initiates | $3 | +1,470.68% | Sep 22, 2023 |
EF Hutton | EF Hutton | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +5,135.60% | May 25, 2023 |
EF Hutton | EF Hutton | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +3,041.36% | May 18, 2023 |
EF Hutton | EF Hutton | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +3,041.36% | May 10, 2023 |
JonesTrading | JonesTrading | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +1,994.24% | Apr 19, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.27
from -0.83
EPS Next Year
-0.17
from -0.27
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | n/a | n/a | n/a |
Avg | n/a | n/a | n/a |
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | -0.27 | -0.18 | -0.18 | |
Avg | -0.27 | -0.17 | -0.17 | |
Low | -0.25 | -0.17 | -0.17 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | - | - | - | |
Avg | - | - | - | |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.